Concepedia

Anastasia R. Rugel

AR

Statistics

Publications

6

Citations

138

H-Index

6

Active since

2015

Affiliations

The University of Texas at San Antonio Health Science Center(Current)

Texas Biomedical Research Institute

South Texas Veterans Health Care System

The University of Texas at San Antonio

Anastasia R. Rugel is an author at The University of Texas at San Antonio Health Science Center specializing in pharmacology, schistosomicidal agents, and schistosomiasis treatment.

Publications per year

2015–2020

6

Publications

6

Independent origins of loss-of-function mutations conferring oxamniquine resistance in a Brazilian schistosome population

Frédéric D. Chevalier, Winka Le Clecʼh, Nina Eng et al. · International Journal for Parasitology · 2016 · 41 citations · Full text

, , +17

Design, Synthesis, and Characterization of Novel Small Molecules as Broad Range Antischistosomal Agents

Anastasia R. Rugel, Reid S. Tarpley, Ambrosio Lopez et al. · ACS Medicinal Chemistry Letters · 2018 · 26 citations · Full text

, , +17

Structural and Functional Characterization of the Enantiomers of the Antischistosomal Drug Oxamniquine

Alexander B. Taylor, Livia Pica‐Mattoccia, C. Polcaro et al. · PLoS neglected tropical diseases · 2015 · 22 citations · Full text

, , +15

Why does oxamniquine kill Schistosoma mansoni and not S. haematobium and S. japonicum?

Anastasia R. Rugel, Meghan A. Guzman, Alexander B. Taylor et al. · International Journal for Parasitology Drugs and Drug Resistance · 2020 · 22 citations · Full text

, , +14

An iterative process produces oxamniquine derivatives that kill the major species of schistosomes infecting humans

Meghan A. Guzman, Anastasia R. Rugel, Reid S. Tarpley et al. · PLoS neglected tropical diseases · 2020 · 15 citations · Full text

, , +17

1–5 of 6